To the full analysis
Buyback calculator for Shenzhen New Industries Biomedical Engineering
Shenzhen New Industries Biomedical Engineering stock: key metrics
300832.SZShenzhen New Industries Biomedical Engineering had an operating margin of 41.1% and a return on invested capital (ROIC) of 28.1% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2012 | 67.2% | 32.8% | 29.1% |
| 2013 | 72.3% | 42.4% | 37.4% |
| 2014 | 76.0% | 50.3% | 46.4% |
| 2015 | 75.7% | 36.9% | 34.0% |
| 2016 | 78.8% | 54.3% | 49.0% |
| 2017 | 78.7% | 55.2% | 47.2% |
| 2018 | 80.8% | 58.4% | 50.2% |
| 2019 | 80.0% | 53.5% | 45.9% |
| 2020 | 77.2% | 50.0% | 42.8% |
| 2021 | 71.2% | 44.7% | 38.3% |
| 2022 | 70.3% | 49.3% | 43.6% |
| 2023 | 72.9% | 48.2% | 42.1% |
| 2024 | 72.1% | 46.5% | 40.3% |
| 2025 | 69.3% | 41.1% | 35.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2012 | 30.3% | 83.3% | 24.0% |
| 2013 | 37.3% | 89.1% | 26.1% |
| 2014 | 41.4% | 80.4% | 33.9% |
| 2015 | 24.3% | 52.7% | 21.7% |
| 2016 | 31.8% | 82.5% | 28.1% |
| 2017 | 30.4% | 88.9% | 26.6% |
| 2018 | 29.3% | 85.5% | 26.3% |
| 2019 | 24.6% | 73.8% | 22.3% |
| 2020 | 19.5% | 72.7% | 17.7% |
| 2021 | 17.4% | 53.9% | 15.9% |
| 2022 | 20.8% | 50.3% | 18.9% |
| 2023 | 21.9% | 44.0% | 20.1% |
| 2024 | 21.3% | 35.6% | 19.0% |
| 2025 | 17.7% | 28.1% | 16.3% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 3 Jul 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.